These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 35069683)
21. A novel pyroptosis-associated gene signature for immune status and prognosis of cutaneous melanoma. Wu Z; Chen L; Jin C; Xu J; Zhang X; Yao Y PeerJ; 2021; 9():e12304. PubMed ID: 34721986 [TBL] [Abstract][Full Text] [Related]
22. Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma. Zhao J; Liu Z; Zheng X; Gao H; Li L Front Genet; 2021; 12():753680. PubMed ID: 34819946 [No Abstract] [Full Text] [Related]
23. Comprehensive Bioinformatics Analysis of Gasdermin Family of Glioma. Zi H; Tuo Z; He Q; Meng J; Hu Y; Li Y; Yang K Comput Intell Neurosci; 2022; 2022():9046507. PubMed ID: 35463276 [TBL] [Abstract][Full Text] [Related]
24. The Dark Side of Pyroptosis of Diffuse Large B-Cell Lymphoma in B-Cell Non-Hodgkin Lymphoma: Mediating the Specific Inflammatory Microenvironment. Wang W; Xu SW; Teng Y; Zhu M; Guo QY; Wang YW; Mao XL; Li SW; Luo WD Front Cell Dev Biol; 2021; 9():779123. PubMed ID: 34805183 [No Abstract] [Full Text] [Related]
25. Comprehensive analysis of pyroptosis regulation patterns and their influence on tumor immune microenvironment and patient prognosis in glioma. Fan T; Wan Y; Niu D; Wang B; Zhang B; Zhang Z; Zhang Y; Gong Z; Zhang L Discov Oncol; 2022 Mar; 13(1):13. PubMed ID: 35274175 [TBL] [Abstract][Full Text] [Related]
26. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas. Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L Front Immunol; 2020; 11():603341. PubMed ID: 33363544 [TBL] [Abstract][Full Text] [Related]
27. Extended Application of Genomic Selection to Screen Multi-Omics Data for the Development of Novel Pyroptosis-Immune Signatures and Predicting Immunotherapy of Glioma. Ma S; Wang F; Wang N; Jin J; Yan X; Wang L; Zheng X; Hu S; Du J Front Pharmacol; 2022; 13():893160. PubMed ID: 35620284 [TBL] [Abstract][Full Text] [Related]
28. Molecular Characteristics, Clinical Implication, and Cancer Immunity Interactions of Pyroptosis-Related Genes in Breast Cancer. Xu D; Ji Z; Qiang L Front Med (Lausanne); 2021; 8():702638. PubMed ID: 34589498 [No Abstract] [Full Text] [Related]
29. A Pyroptosis-Related Gene Prognostic Index Correlated with Survival and Immune Microenvironment in Glioma. Zheng J; Zhou Z; Qiu Y; Wang M; Yu H; Wu Z; Wang X; Jiang X J Inflamm Res; 2022; 15():17-32. PubMed ID: 35018108 [TBL] [Abstract][Full Text] [Related]
30. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis. Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353 [TBL] [Abstract][Full Text] [Related]
31. Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature. Zeng R; Huang S; Qiu X; Zhuo Z; Wu H; Jiang L; Sha W; Chen H Front Pharmacol; 2021; 12():767187. PubMed ID: 34867395 [TBL] [Abstract][Full Text] [Related]
32. Bulk and Single-Cell Transcriptome Analyses Revealed That the Pyroptosis of Glioma-Associated Macrophages Participates in Tumor Progression and Immunosuppression. Li L; Wu L; Yin X; Li C; Hua Z Oxid Med Cell Longev; 2022; 2022():1803544. PubMed ID: 36199426 [TBL] [Abstract][Full Text] [Related]
33. Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma. Xing Z; Liu Z; Fu X; Zhou S; Liu L; Dang Q; Guo C; Ge X; Lu T; Zheng Y; Dai L; Han X; Wang X Front Cell Dev Biol; 2022; 10():805291. PubMed ID: 35223836 [No Abstract] [Full Text] [Related]
34. Comprehensive Analysis of Pyroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients with Colon Cancer. Liu L; Chen W; Li Y; Fu P; Cao Y; Li Z; Xiong J; Jie Z J Oncol; 2022; 2022():2035808. PubMed ID: 35087586 [TBL] [Abstract][Full Text] [Related]
35. A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma. Zhong J; Liu J; Huang Z; Zheng Y; Chen J; Ji J; Chen T; Ke Y Front Genet; 2022; 13():1026192. PubMed ID: 36353102 [No Abstract] [Full Text] [Related]
36. Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas. Zhou Z; Wei J; Lu B; Jiang W; Bao Y; Li L; Wang W Front Genet; 2021; 12():763807. PubMed ID: 35198000 [No Abstract] [Full Text] [Related]
37. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas. Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of multi-omics data of recurrent gliomas identifies a recurrence-related signature as a novel prognostic marker. Wang QW; Zhao Z; Bao ZS; Jiang T; Zhu YJ Am J Cancer Res; 2021; 11(4):1226-1246. PubMed ID: 33948355 [TBL] [Abstract][Full Text] [Related]
39. A Novel Pyroptosis-Related Gene Signature for Predicting Prognosis in Kidney Renal Papillary Cell Carcinoma. Hu J; Chen Y; Gao L; Ge C; Xie X; Lei P; Zhang Y; Liang P Front Genet; 2022; 13():851384. PubMed ID: 35401700 [TBL] [Abstract][Full Text] [Related]
40. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature. Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]